Imagine if you could track your brain waves while sleeping at home as accurately as in a hospital, but without being hooked up to a giant machine. This technology uses a 'smart skin' patch that sticks to you like a temporary tattoo to record sleep patterns. It turns a complex overnight hospital stay into a simple home test that a doctor can review online.
Traditional sleep diagnosis requires expensive, unnatural, and unavailable overnight hospital stays (PSG). This leads to under-reporting and unrecognized sleep disorders in a huge portion of the population.
A home-based sleep monitoring system consisting of Smart Skin dry electrodes, a Data Acquisition Unit, and a cloud-based platform for report generation.
If you are a telemedicine platform dealing with the lack of reliable home diagnostic tools for sleep—this project developed a Smart Skin electrode system that allows patients to record medical-grade brain waves at home. This enables remote diagnosis and treatment monitoring without requiring hospital visits.
If you are a wearable manufacturer dealing with the low signal quality of consumer-grade sleep trackers—this project developed printed electrodes and data acquisition units that capture REM sleep and spindles. This provides a medical-grade alternative to traditional Polysomnography (PSG).
If you are a sleep clinic dealing with high costs and limited capacity of overnight PSG labs—this project developed a home-based test for self-use. This allows you to scale your patient intake by moving the initial screening and monitoring from the clinic to the patient's home.
Based on available project data, the system is designed to replace Polysomnography (PSG), which is described as having a high cost, though specific pricing for S-trodes is not provided.
The project has already completed the production of the first batch of electrode arrays for clinical study, indicating the start of a manufacturing process.
Based on available project data, the technology is developed by X-trodes Ltd, but specific licensing terms or patents are not listed in the summary.
The project is currently performing clinical validation activities to obtain the CE Mark for commercialization in Europe.
The project runs until 2026-01-31, with auto-scoring algorithm verification expected during 2025 and a possibility of early CE submission.
The project is led by a single SME, X-TRODES LTD from Israel. With a 100% industry ratio and no university or research partners, the consortium is lean and focused entirely on commercialization and product development rather than basic research.
Contact X-TRODES LTD regarding the S-trodes clinical validation results.
Contact us to explore licensing opportunities for Smart Skin electrode technology.
